Cosmo Bio USA provides a specialized Cells & Cell Separation product portfolio developed for advanced research applications in immunology, stem cell biology, regenerative medicine, and biotherapeutic development. Serumwerk Bernburg contributes clinical-grade density gradient media—including Lymphoprep™, Polymorphprep™, Nycodenz™, and OptiPrep™—for the isolation of mononuclear cells, granulocytes, and subcellular components such as viruses and extracellular vesicles. Cosmo Bio Co., Ltd. supplements this selection with a diverse range of primary cells, including mesenchymal stem cells and immune cell populations, as well as extracellular matrix proteins such as fibronectin and laminin. Their cell separation reagents facilitate enhanced cell purification, adhesion, and culture optimization for consistent experimental outcomes.
The portfolio is further expanded by Cellular Engineering Technologies (CET), which supplies human primary cells, induced pluripotent stem cells, and immortalized cell lines manufactured under xeno-free, defined conditions for translational and regenerative applications. JSR Corporation provides advanced magnetic bead technologies for efficient immunomagnetic cell isolation—optimized for cell therapy applications, rare cell enrichment protocols, and immunological research. Tokyo Ohka Kogyo (TOK) complements the collection with the Sieve Well Slide, a precision-engineered microwell array platform enabling high-throughput single-cell isolation, microscopic analysis, and clonal cell selection. These validated methodologies demonstrate Cosmo Bio USA's dedication to facilitating advancement in cell-based research, supporting developments in therapeutic applications and precision medicine.